Argos Therapeutics Inc

Type: Company
Name: Argos Therapeutics Inc
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

Argos Therapeutics Inc. raises $25mm in venture loan

Personalized immunotherapy company Argos Therapeutics Inc. raised $25mm through a venture loan led by Horizon Technology Finance Corp. The debt will be funded in two tranches of $12.5mm each, the first being a four-year senior secured term loan (inte ... [Published BioPortfolio - Oct 17 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Global Therapeutics Market shows a tremendous growth

Vaccines can be classified into two types, namely Prophylactic and Therapeutic vaccine. Prophylactic vaccine is used to prevent infection caused by any wild or natural pathogen; whereas, therapeutic vaccines are developed to induce an attack against any ... [Published PharmiWeb - Oct 13 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 1 reports

Tuesday business briefs 10-7

DPx to expand in Pitt CountyRALEIGH — DPx Holdings B.V. and its business unit Patheon , a provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will expand its operations in Pitt County. The company ... [Published Courier Tribune - Oct 06 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 1 reports

BioNews [10.6.14]

Top News HeadlineCompanyType Alcobra says its ADHD drug works–as long as you don't compare it to placebo AlcobraADHD Treatment SSF-Based Sunesis Pharmaceuticals Shares Crater After Failed Phase 3 Cancer Drug Study Sunesis Pharmaceut ... [Published eClinical Trends - Oct 06 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 2 reports

Argos plans for new manufacturing facility in Durham North Carolina

Argos Therapeutics (ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis technology platform, has announced pla ... [Published BioPortfolio - Oct 06 2014]
First reported Oct 04 2014 - Updated Oct 04 2014 - 1 reports

Therapeutics company adding 236 jobs in Durham

Argos Therapeutics said Friday it will expand in Durham, adding 236 jobs by the end of 2018 and spending $56.6 million on capital investments to build a commercial bio-manufacturing facility that would be compliant with Food and Drug Administration g ... [Published Winston-Salem Journal - Oct 04 2014]
First reported Oct 03 2014 - Updated Oct 04 2014 - 5 reports

Argos Therapeutics : Expanding in Durham

RALEIGH, N.C. , Oct. 3 -- Gov. Pat McCrory , R- N.C. , issued the following news release:Governor Pat McCrory and North Carolina Commerce Secretary Sharon Decker announced today that Argos Therapeutics will be expanding in Durham County . The company ... [Published 4 Traders - Oct 04 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Argos confirms plans to hire 236 in Durham, invest $57M in new biomanufacturing plant

There’s been a lot of speculation the last few months about when – and where – Durham-based Argos Therapeutics would be building its expensive new biomanufacturing plant for the production of its the immunotherapy drug candidates currently in phase three ... [Published Triangle Business Journal - Oct 03 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

N.C. incentives approved for Argos Therapeutics, Patheon expansions

Durham-based Argos Therapeutics has snagged more than $5 million in state incentives to construct its 100,000-square-foot drug manufacturing county in Durham County.That's one of the announcements to come out of an Economic Investment Committee meeting ... [Published Triangle Business Journal - Oct 03 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Argos Therapeutics to Present at the 13th Annual BIO Investor Forum

DURHAM, N.C., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. ( Nasdaq:ARGS ), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases ... [Published Town Hall - Oct 01 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Horizon Technology Leads Argos Venture Loan Facility

Argos Therapeutics announced it entered into a $25 million venture loan led by Horizon Technology Finance. Argos plans to devote the loan proceeds to the continuing development of AGS-003, the company’s lead oncology product candidate, being evaluated ... [Published ABF Journal - Oct 01 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Business briefs, Oct. 1

7 regional companies semi-finalists for grantsFor the 18 th NC IDEA grant cycle, seven start-up companies in the Durham-Chapel Hill region were named semi-finalists out of a total of 19 companies.NC IDEA selected the semifinalists from about 100 applications ... [Published Durham Herald-Sun - Oct 01 2014]

Quotes

...for our growth capital as we funded nine venture loans to new and existing portfolio companies," said Gerald A Michaud, President of Horizon. "In addition, we experienced five liquidity events, which included realizing gains from the exercise and sale of warrants. The strong demand for our growth capital loan products is further evidenced by our committed backlog more than doubling in size from the end of the second quarter. With the positive liquidity events of the third quarter, Horizon is positioned to take advantage of its liquidity and grow its portfolio."
NEXT ARTICLE More From BioPortfolio on "Argos plans for new manufacturing facility in Durham, North Carolina"
...is an important part of Durham County's economy, and this announcement by Argos Therapeutics is welcome news," said Representative Mickey Michaux . "It is always great when one of our existing companies is able to grow and expand."

More Content

All (51) | News (32) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (17)
sort by: Date | Relevance
Argos Therapeutics Inc. raises $25mm in venture... [Published BioPortfolio - Oct 17 2014]
Global Therapeutics Market shows a tremendous g... [Published PharmiWeb - Oct 13 2014]
With over 1,500 clinical stage deals announced ... [Published Live-PR.com - Oct 09 2014]
Horizon Technology Finance Provides Investment ... [Published U-T San Diego - Oct 08 2014]
Tuesday business briefs 10-7 [Published Courier Tribune - Oct 06 2014]
BioNews [10.6.14] [Published eClinical Trends - Oct 06 2014]
Argos plans for new manufacturing facility in D... [Published BioPortfolio - Oct 06 2014]
Argos plans for new manufacturing facility in D... [Published PBR - News - Oct 06 2014]
Argos Therapeutics : Expanding in Durham [Published 4 Traders - Oct 04 2014]
Therapeutics company adding 236 jobs in Durham [Published Winston-Salem Journal - Oct 04 2014]
Argos CEO: 'I was so glad we had made the decis... [Published Triangle Business Journal - Oct 03 2014]
Argos confirms plans for new HQ [Published Durham Herald-Sun - Oct 03 2014]
Argos confirms plans to hire 236 in Durham, inv... [Published Triangle Business Journal - Oct 03 2014]
Bio-Pharma Company Argos Therapeutics Invest $5... [Published Area Development - Oct 03 2014]
Update: Drug firm Patheon adding 488 jobs in Gr... [Published Local Tech Wire - Oct 03 2014]
Durham drug firm Argos to add 230 jobs, gets $9... [Published Local Tech Wire - Oct 03 2014]
Argos Therapeutics Announces Plans for New Manu... [Published GlobeNewswire: Acquisitions News - Oct 03 2014]
Argos Therapeutics Announces Plans for New Manu... [Published Street Sweeper - Oct 03 2014]
N.C. incentives approved for Argos Therapeutics... [Published Triangle Business Journal - Oct 03 2014]
Argos Therapeutics to Present at the 13th Annua... [Published GlobeNewswire: Advertising News - Oct 01 2014]
Argos Therapeutics to Present at the 13th Annua... [Published Town Hall - Oct 01 2014]
Horizon Technology Leads Argos Venture Loan Fac... [Published ABF Journal - Oct 01 2014]
Business briefs, Oct. 1 [Published Durham Herald-Sun - Oct 01 2014]
XOMA Initiates Trial of Gevokizumab; Sarepta Re... [Published BioMedReports - Oct 01 2014]
Argos Therapeutics Enters Into $25 Million Vent... [Published GlobeNewswire: Acquisitions News - Sep 30 2014]
Nektar Presents Positive Preclinical Data on Ka... [Published BioMedReports - Sep 20 2014]
Argos Therapeutics to Present at the 21st Annua... [Published GlobeNewswire: Acquisitions News - Sep 19 2014]
Argos Therapeutics to Present at the 21st Annua... [Published Industrial Info Financials - Sep 19 2014]
Argos Therapeutics to Present at the 21st Annua... [Published Fat Pitch Financials - Sep 19 2014]
Enrollment in Argos Therapeutics' Pivotal Phase... [Published GlobeNewswire: Advertising News - Sep 18 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioNews [10.6.14] [Published eClinical Trends - Oct 06 2014]
Top News HeadlineCompanyType Alcobra says its ADHD drug works–as long as you don't compare it to placebo AlcobraADHD Treatment SSF-Based Sunesis Pharmaceuticals Shares Crater After Failed Phase 3 Cancer Drug Study Sunesis Pharmaceut ...
Argos plans for new manufacturing facility in D... [Published PBR - News - Oct 06 2014]
Argos Therapeutics (ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis technology platform, has announced plans ...
1

Press Releases

sort by: Date | Relevance
Argos Therapeutics Announces Plans for New Manu... [Published GlobeNewswire: Acquisitions News - Oct 03 2014]
Argos Therapeutics to Present at the 13th Annua... [Published GlobeNewswire: Advertising News - Oct 01 2014]
Argos Therapeutics Enters Into $25 Million Vent... [Published GlobeNewswire: Acquisitions News - Sep 30 2014]
Argos Therapeutics to Present at the 21st Annua... [Published GlobeNewswire: Acquisitions News - Sep 19 2014]
Enrollment in Argos Therapeutics' Pivotal Phase... [Published GlobeNewswire: Advertising News - Sep 18 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.